Literature DB >> 26085097

A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.

Min Zhao1, Xiao-Jing Li1, Zi-Min Tang2, Fan Yang2, Si-Ling Wang2, Wei Cai1, Ke Zhang2, Ning-Shao Xia3, Zi-Zheng Zheng4.   

Abstract

The hepatitis E virus (HEV) ORF2 encodes a single structural capsid protein. The E2s domain (amino acids 459-606) of the capsid protein has been identified as the major immune target. All identified neutralizing epitopes are located on this domain; however, a comprehensive characterization of antigenic sites on the domain is lacking due to its high degree of conformation dependence. Here, we used the statistical software SPSS to analyze cELISA (competitive ELISA) data to classify monoclonal antibodies (mAbs), which recognized conformational epitopes on E2s domain. Using this novel analysis method, we identified various conformational mAbs that recognized the E2s domain. These mAbs were distributed into 6 independent groups, suggesting the presence of at least 6 epitopes. Twelve representative mAbs covering the six groups were selected as a tool box to further map functional antigenic sites on the E2s domain. By combining functional and location information of the 12 representative mAbs, this study provided a complete picture of potential neutralizing epitope regions and immune-dominant determinants on E2s domain. One epitope region is located on top of the E2s domain close to the monomer interface; the other is located on the monomer side of the E2s dimer around the groove zone. Besides, two non-neutralizing epitopes were also identified on E2s domain that did not stimulate neutralizing antibodies. Our results help further the understanding of protective mechanisms induced by the HEV vaccine. Furthermore, the tool box with 12 representative mAbs will be useful for studying the HEV infection process.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  E2s domain; SPSS; antigen; clustering analysis; conformational mAbs; hepatitis virus; monoclonal antibody; protein structure; tool box; vaccine development

Mesh:

Substances:

Year:  2015        PMID: 26085097      PMCID: PMC4528150          DOI: 10.1074/jbc.M115.649764

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes.

Authors:  L Xing; K Kato; T Li; N Takeda; T Miyamura; L Hammar; R H Cheng
Journal:  Virology       Date:  1999-12-05       Impact factor: 3.616

2.  Expression and self-assembly of empty virus-like particles of hepatitis E virus.

Authors:  T C Li; Y Yamakawa; K Suzuki; M Tatsumi; M A Razak; T Uchida; N Takeda; T Miyamura
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies.

Authors:  T R Luo; N Minamoto; M Hishida; K Yamamoto; T Fujise; S Hiraga; N Ito; M Sugiyama; T Kinjo
Journal:  Microbiol Immunol       Date:  1998       Impact factor: 1.955

Review 4.  Hepatitis E virus: molecular biology and diagnosis.

Authors:  I K Mushahwar; G J Dawson; G R Reyes
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-04       Impact factor: 2.566

5.  Safety and efficacy of a recombinant hepatitis E vaccine.

Authors:  Mrigendra Prasad Shrestha; Robert McNair Scott; Durga Man Joshi; Mammen P Mammen; Gyan Bahadur Thapa; Narbada Thapa; Khin Saw Aye Myint; Marc Fourneau; Robert A Kuschner; Sanjaya Kumar Shrestha; Marie Pierre David; Jitvimol Seriwatana; David W Vaughn; Assad Safary; Timothy P Endy; Bruce L Innis
Journal:  N Engl J Med       Date:  2007-03-01       Impact factor: 91.245

6.  Monoclonal antibodies raised against the ORF3 protein of hepatitis E virus (HEV) can capture HEV particles in culture supernatant and serum but not those in feces.

Authors:  Masaharu Takahashi; Kentaro Yamada; Yu Hoshino; Hideyuki Takahashi; Koji Ichiyama; Toshinori Tanaka; Hiroaki Okamoto
Journal:  Arch Virol       Date:  2008-08-05       Impact factor: 2.574

7.  Characterization of monoclonal antibodies to hepatitis E virus (HEV) capsid protein and identification of binding activity.

Authors:  Junkun He; Robert A Kuschner; Vincent Dewar; Pierre Voet; Ludmila V Asher; David W Vaughn
Journal:  J Biomed Sci       Date:  2007-05-09       Impact factor: 8.410

8.  Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease.

Authors:  J P Bryan; S A Tsarev; M Iqbal; J Ticehurst; S Emerson; A Ahmed; J Duncan; A R Rafiqui; I A Malik; R H Purcell
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

9.  Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes.

Authors:  Minxi Wei; Xiao Zhang; Hai Yu; Zi-Min Tang; Kaihang Wang; Zhongyi Li; Zizheng Zheng; Shaowei Li; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Vaccine       Date:  2014-03-22       Impact factor: 3.641

10.  Putative receptor-binding sites of hepatitis E virus.

Authors:  Shuizhen He; Ji Miao; Zizheng Zheng; Ting Wu; Minghui Xie; Ming Tang; Jun Zhang; Mun-Hon Ng; Ningshao Xia
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

View more
  18 in total

Review 1.  Development of new hepatitis E vaccines.

Authors:  Yufeng Cao; Zhenhong Bing; Shiyu Guan; Zecai Zhang; Xinping Wang
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 3.452

2.  Dynamics of 8G12 competitive antibody in "prime-boost" vaccination of Hepatitis E vaccine.

Authors:  Xing Wu; Pan Chen; Huijuan Lin; Yao Su; Xiaotian Hao; Yufeng Cao; Li Li; Fengcai Zhu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

3.  Effect of freezing on recombinant hepatitis E vaccine.

Authors:  Kelei Li; Fangyu Dong; Fan Gao; Lianlian Bian; Shiyang Sun; Ruixiao Du; Yalin Hu; Qunying Mao; Haifa Zheng; Xing Wu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2019-12-06       Impact factor: 3.452

4.  Functional epitopes on hepatitis E virions and recombinant capsids are highly conformation-dependent.

Authors:  Bin He; Zhigang Zhang; Xinyuan Zhang; Zimin Tang; Chang Liu; Zizheng Zheng; Shaowei Li; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452

5.  Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection.

Authors:  Xin Yin; Dong Ying; Sébastien Lhomme; Zimin Tang; Christopher M Walker; Ningshao Xia; Zizheng Zheng; Zongdi Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-18       Impact factor: 11.205

6.  Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.

Authors:  Yiyang Chen; Baoyuan Liu; Yani Sun; Huixia Li; Taofeng Du; Yuchen Nan; Julian A Hiscox; En-Min Zhou; Qin Zhao
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

7.  Full genome analysis of swine genotype 3 hepatitis E virus isolated from eastern China.

Authors:  Jiang-Bing Shuai; Lu-Huan Li; Ai-Yun Li; Yong-Qiang He; Xiao-Feng Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2017-06       Impact factor: 3.066

8.  A broadly cross-reactive monoclonal antibody against hepatitis E virus capsid antigen.

Authors:  Barbara Kubickova; Jörg A Schenk; Franziska Ramm; Kornelija Markuškienė; Jochen Reetz; Paul Dremsek; Paulius Lukas Tamosiunas; Laima Cepulyte; Hoai Anh Trinh; Johannes Scholz; Henry Memczak; Marc Hovestädt; René Ryll; Rasa Petraityte-Burneikiene; Victor M Corman; Anika Andersson; Dietmar Becher; Martin H Groschup; Stefan Kubick; Frank Sellrie; Reimar Johne; Rainer G Ulrich
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-15       Impact factor: 4.813

9.  A high-throughput neutralizing assay for antibodies and sera against hepatitis E virus.

Authors:  Wei Cai; Zi-Min Tang; Gui-Ping Wen; Si-Ling Wang; Wen-Fang Ji; Min Yang; Dong Ying; Zi-Zheng Zheng; Ning-Shao Xia
Journal:  Sci Rep       Date:  2016-04-28       Impact factor: 4.379

Review 10.  Role of Envelopment in the HEV Life Cycle.

Authors:  Xin Yin; Xinlei Li; Zongdi Feng
Journal:  Viruses       Date:  2016-08-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.